Objective: To describe the clinical and demographic characteristics of non-Hodgkin's lymphoma patients diagnosed at the Pediatric Oncology Unit at the Instituto Materno-Infantil Professor Fernando Figueira (IMIP) over a 9-year period, and also to describe their survival rates and possible associations between the survival rates and the clinical and demographic characteristics analyzed in the study.
Introduction
Although rare in childhood, lymphoma among children and adolescents has been receiving ever-growing attention among researchers, not just because of its growing importance from the epidemiological point of view, but also because of the major advances observed in diagnosis and treatment.
Malignant neoplasms are the second cause of child death in developed countries and the fourth cause of death among children and adolescents in Brazil, and they are the second most frequent cause of death, in our country, in the age range five to 9 years, among whom they are only less common than deaths from external causes. 1, 2 In this context, lymphomas are the third most frequently diagnosed malignant neoplasm among children and adolescents in the age range 0 to 15 years, with 60% of cases being non-Hodgkin's lymphoma (NHL) and 40% being Hodgkin lymphomas.
Depending on the geographic region being studied, there are important differences in relation to the clinical and epidemiological characteristics of NHLs diagnosed during childhood. 3, 4 In equatorial Africa, the Burkitt histological subtype of NHL accounts for 50% of all cancers diagnosed in the pediatric age group and has a high incidence of primary tumors involving the jaw, whereas in the rest of the world, this neoplasm accounts for less than 5% of pediatric cancers, and abdominal primary tumors are the most common presentation. 3, 5 In the northeast of Brazil, a high frequency of the Burkitt histological subtype has also been reported in the past. 6, 7 Among the prognostic factors of childhood NHL that have been studied, the factor with greatest consensus in the literature is the tumor burden at the time of diagnosis, normally quantified by staging and serum lactate dehydrogenase (LDH) Serum LDH assays were performed within 24 hours of patient admission, being considered elevated when over 500 UI/dL (International Units per deciliter).
The therapeutic regimen was prescribed depending on histological typing and/or immunophenotype of the lymphoma and on the period during which the patient was admitted. Burkitt's and large B-cell lymphomas and/or those where the primary site was abdominal were treated with a chemotherapy protocol based on the LMB-89. 11 With the aim of reducing toxicity related to the intensity of the chemotherapy regimen, from 1995 to 1997 a modified LMB-89 protocol was employed, with the following changes to the original protocol:
-Reduction of methotrexate dose to 1 g/m 2 in groups B and C.
-No cyclophosphamide dosage to be scaled up above 500 mg/m 2 /day during COPADM courses.
-Substitution of the chemotherapy cycle known as CYVE by CYM, during consolidation of branch C of the protocol.
A therapeutic protocol based on the Total XIIIB-SJCRH was used for lymphoblastic lymphomas or large cell lymphomas of T cells and/or where the primary site was not abdominal. 12 Treatment based on the LSA2L2 protocol 13 was used for patients admitted during the first year of the service's operations, before the protocols described above were adopted. Of the patients who achieved remission, seven (7.4%) have relapsed and 15 (16%) died, 11 during first remission and four after a relapse.
The overall 2 and 5 year survival rates of our study were 73%±4% and 70%±4%, respectively ( Figure 1 ).
Disease-free survival was 70%±4% at 2 years and 68%±4%, at 5 years. None of the clinical, epidemiological or socioeconomic variables exhibited a statistically significant association with global survival or disease-free survival (p > 0.05) ( Table 2) .
Discussion
Little data can be found in the Brazilian medical literature relating to the behavior of NHLs in the infant and juvenile population of our region. This study describes the epidemiological, clinical and socioeconomic characteristics of children with NHLs who were treated in a region where resources are limited.
We reviewed the medical records of 110 patients admit- The incidence of NHL increases uniformly with age and is rarely diagnosed before 2 years. 3 In our study we observed that NHL affects younger children than those described in foreign literature and this fact is compatible with other reports that have described other Brazilian experiences. 6, 7, 15, 16 The possibility of infectious etiology, principally related to the Epstein-Barr virus, 4 being involved in the pathogenesis of Burkitt lymphomas may be a partial explanation for the emergence of this disease in younger patients in our region, since it is believed that populations in less privileged socioeconomic situations are exposed to infectious agents earlier.
With relation to sex, a predominance of male cases was observed, in a proportion of 2.4:1, which is similar to what is described in the literature. 4 When we compared our rate of malnutrition with other studies involving Brazilian children with malignant neoplasms, we observed that our rate was lower than the others, 15, 17 which is a fact that warrants more profound analysis, since both studies used similar methodology to ours to define malnutrition.
The percentage of maternal illiteracy was lower in our group when compared with data from another research project carried out in our region, 18 which makes us suppose that perhaps some children with NHL, who were the children of illiterate mothers, may have had healthcare access difficulties, because of their mothers' scant understanding of the health-disease process, among other reasons. We found evidence of a high prevalence of NHL of the Burkitt histological subtype (78.2%), when compared with American and European data. 3 Sandlund et al. 6 have previously made the same observation with relation to the distribution of histological types, reporting a frequency of 94% of Burkitt's lymphoma in children with NHL in our region.
This finding suggests that, in our children, Burkitt's lymphoma has a similar pattern of frequency to African Burkitt's lymphoma, 5 although with clinical presentation that is essentially abdominal, similar to sporadic Burkitt lymphomas.
Evidence relating certain biological characteristics of Burkitt lymphomas, such as the association with the EpsteinBarr virus (EBV) and the point at which chromosome 8 is broken, supports the view that there are pathogenetically distinct subtypes of Burkitt's lymphoma in different regions of the world, 4 which could make us suppose that the patients in our study exhibit a type that is biologically distinct of the NHLs described in endemic (Africa) and sporadic variety (rest of world). However, in the light of current knowledge, this hypothesis cannot be confirmed, and further studies are needed into the subject in order that this question may be answered.
The survival of our patients approaches, although it remains inferior, to the results being currently presented by the major collaborative childhood cancer treatment groups, who report survival of around 80 to 90% for patients with NHL (Table 3) .
However, we found that around 50% of our deaths (16 out of 31 deaths) occurred during the first 30 days after admission, being defined as early deaths that were frequently associated with comorbidities, such as metabolic, compressive and infectious complications, related to advanced disease stages.
Excluding these deaths from our survival analysis, we observed a survival rate of around 80% at 2 years, close to the best results reported in the current period.
We therefore believe that efforts to reduce the rate of early deaths are essential, improving the clinical condition of these The impact of such measures has already resulted in improved survival among our acute lymphoblastic leukemia patients, as Howard et al. 28 have described, and maybe related to the decreasing in early death rate observed in this study over the 9 years of our analysis.
In relation to the attempt to identify prognostic factors, no statistically significant associations were demonstrated between the clinical, epidemiological and socioeconomic variables and either global survival or disease-free survival in our study, which may be due to insufficient sample size or may be related to the important socioeconomic support that the families of our patients are given by a nongovernmental institution, which has been cited above as one possible cause of the improvements in survival among children with cancer in countries with limited resources. 28 Finally, we suggest that further studies be carried out in order to better define prognostic factors and in order to elucidate etiopathogenic factors that could be associated with the differences in the form of presentation of NHLs among children in our region.
